Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on April 17, 2025
Do Probiotics Make You Poop? Probiotic & Prebiotic Supplement For Constipation From YourBiology
GlobeNewswire
·
April 17, 2025
Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- Some cultured foods and the living bacteria and yeasts present naturally in the human body may aid in gastrointestinal health maintenance. Do Probiotics Make You Poop? What to Know On the other hand, …
Injectable Drug Delivery Devices Market Set to Reach $317.2 Billion by 2029
GlobeNewswire
·
April 17, 2025
Boston, April 17, 2025 (GLOBE NEWSWIRE) -- BCC Research reveals in its new report, Global Injectable Drug Delivery Devices Market, the market for injectable drug delivery devices is projected to grow to $317.2 billion by 2029 at a five-year compound annual …
uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease
GlobeNewswire
·
April 17, 2025
~ Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~ ~ Additional regulatory update and guidance on the Biologics License Application submission expected in the second …
Amwell® to report first quarter 2025 operating results
GlobeNewswire
·
April 17, 2025
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire …
EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing in Approved Indications
GlobeNewswire
·
April 17, 2025
If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated for all other anti-VEGF therapies Potential for as …
Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025
GlobeNewswire
·
April 17, 2025
CAMBRIDGE, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the company will host a conference …
New Study Reveals Promise of Text-Based Mental Health Support App Counslr in Decreasing Barriers to Mental Health Support
GlobeNewswire
·
April 17, 2025
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Counslr, a leading B2B mental health and wellness platform, announced today the publication of a new study in JMIR Formative Research titled “Evaluating User Engagement with a Real-Time, Text-Based Digital …
Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders
GlobeNewswire
·
April 17, 2025
NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness …
Enovis to Host First Quarter 2025 Results Conference Call on May 8th
GlobeNewswire
·
April 17, 2025
Wilimington, DE, April 17, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2025 …
Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program
GlobeNewswire
·
April 17, 2025
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea” or “Company”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today …
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
GlobeNewswire
·
April 17, 2025
SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John …
AAFA Announces Innovative Program in Texas Serving Communities Facing Highest Rates of Asthma
GlobeNewswire
·
April 17, 2025
Washington, DC, April 17, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) announces an innovative new collaboration with Health Care Originals, Inc. (HCO) and Rabbit Air as part of AAFA’s Health Equity Advancement and …
Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory Conditions
GlobeNewswire
·
April 17, 2025
Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 GS-6791/NX-0479 has potential clinical applications across multiple blockbuster markets in …
Ostarine (MK 2866) PCT: Ostarine Before & After Result Benefits - Legal Ostarine MK-2866 SARM For Sale From CrazyBulk
GlobeNewswire
·
April 17, 2025
Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- Ostarine, also known as MK-2866, is a SARM that is considered to be on the milder end of the spectrum and is often used by novices. Many people take this to mean that you do not need to complete the PCT …
Milliways, la révolution du chewing-gum, débarque en France
GlobeNewswire
·
April 17, 2025
Milliways, la marque britannique de chewing-gum sans plastique en pleine expansion, annonce son lancement en France avec l’ambition de transformer un marché resté figé depuis des décennies. Déjà leader de la catégorie “plastic-free” au Royaume-Uni, …
How To Get Rid of Herpes: Top OTC Supplements To Get Rid of Herpes From Herpesyl
GlobeNewswire
·
April 17, 2025
New York City, April 17, 2025 (GLOBE NEWSWIRE) -- Herpes is an infection caused by two different viruses - HSV-1 and HSV-2. It is a highly contagious virus that affects a person's physical, emotional, and psychological health. In this article, we explore …
Aveanna Announces First Quarter 2025 Earnings Release Date and Conference Call
GlobeNewswire
·
April 17, 2025
ATLANTA, April 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 8, 2025, to be followed by a conference …
Teleflex Announces First Quarter 2025 Earnings Conference Call Information
GlobeNewswire
·
April 17, 2025
WAYNE, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 1, 2025. To participate …
Is Testosterone a Steroid? TestoPrime – Best Legal Testosterone Supplement For Men Over 40 and 50
GlobeNewswire
·
April 17, 2025
Glasgow City, April 17, 2025 (GLOBE NEWSWIRE) -- The question is asked by those who wish to know if it is identical to the illicit drugs that bodybuilders and sportsmen often take or if it isn't, and here's the reason. The body naturally produces …
Interius BioTherapeutics to Present at Upcoming Scientific Meetings
GlobeNewswire
·
April 17, 2025
PHILADELPHIA, April 17, 2025 (GLOBE NEWSWIRE) -- Interius BioTherapeutics, a clinical-stage company engineering targeted, programmable vectors for the precision delivery of genetic medicines, today announced that it will present at several upcoming …